BREAKING
Home » Posts Tagged "Daklinza"

Hepatitis C: China FDA approves Daklinza and Sunvepra, First all-oral regimen

By

Bristol-Myers Squibb Company announced Friday that the China Food and Drug Administration (CFDA) has approved a direct-acting antiviral regimen comprised of Daklinza ® (daclatasvir) and Sunvepra ®(asunaprevir),...

Bristol-Myers Squibb’s hepatitis C drug, Daklinza, receives FDA approval

By

The U.S. Food and Drug Administration today approved Daklinza (daclatasvir) for use with sofosbuvir to treat hepatitis C virus (HCV) genotype 3 infections. Daklinza is the first drug that has demonstrated...